Sucralfate: Package Insert and Label Information (Page 2 of 2)


Due to limited experience in humans with overdosage of sucralfate, no specific treatment recommendations can be given. Acute oral toxicity studies in animals, however, using doses up to 12 g/kg body weight, could not find a lethal dose. Sucralfate is only minimally absorbed from the gastrointestinal tract. Risks associated with acute overdosage should, therefore, be minimal. In rare reports describing sucralfate overdose, most patients remained asymptomatic. Those few reports where adverse events were described included symptoms of dyspepsia, abdominal pain, nausea, and vomiting.


Active Duodenal Ulcer

The recommended adult oral dosage for duodenal ulcer is 1 g four times per day on an empty stomach.

Antacids may be prescribed as needed for relief of pain but should not be taken within one-half hour before or after sucralfate.

While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination.

Maintenance Therapy

The recommended adult oral dosage is 1 g twice a day.


In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy (see PRECAUTIONS , Geriatric Use).

Call your doctor for medical advice about side effects. You may report side effects to TEVA USA, PHARMACOVIGILANCE at 1-866-832-8537 or; or FDA at 1-800-FDA-1088 or


NDC: 63629-1307-1: 100 Tablets in a BOTTLE

NDC: 63629-1307-2: 60 Tablets in a BOTTLE

NDC: 63629-1307-3: 30 Tablets in a BOTTLE

NDC: 63629-1307-4: 20 Tablets in a BOTTLE

NDC: 63629-1307-6: 150 Tablets in a BOTTLE

NDC: 63629-1307-7: 90 Tablets in a BOTTLE

NDC: 63629-1307-8: 40 Tablets in a BOTTLE

NDC: 63629-1307-9: 120 Tablets in a BOTTLE

NDC: 63629-1307-0: 28 Tablets in a BOTTLE

Sucralfate 1gm Tablet

(click image for full-size original)
sucralfate tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:63629-1307(NDC:0093-2210)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Inactive Ingredients
Ingredient Name Strength
Product Characteristics
Color white Score 2 pieces
Shape OVAL (capsule-shaped) Size 19mm
Flavor Imprint Code TEVA;22;10
# Item Code Package Description Multilevel Packaging
1 NDC:63629-1307-1 100 TABLET in 1 BOTTLE None
2 NDC:63629-1307-2 60 TABLET in 1 BOTTLE None
3 NDC:63629-1307-3 30 TABLET in 1 BOTTLE None
4 NDC:63629-1307-4 20 TABLET in 1 BOTTLE None
5 NDC:63629-1307-6 150 TABLET in 1 BOTTLE None
6 NDC:63629-1307-7 90 TABLET in 1 BOTTLE None
7 NDC:63629-1307-8 40 TABLET in 1 BOTTLE None
8 NDC:63629-1307-9 120 TABLET in 1 BOTTLE None
9 NDC:63629-1307-0 28 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA070848 11/11/1996
Labeler — Bryant Ranch Prepack (171714327)
Registrant — Bryant Ranch Prepack (171714327)
Name Address ID/FEI Operations
Bryant Ranch Prepack 171714327 repack (63629-1307), relabel (63629-1307)

Revised: 05/2023 Bryant Ranch Prepack

Page 2 of 2 1 2 provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.